MGNet: Defining a Treatment-Responsive Biomarker for Corticosteroid Therapy in Myasthenia Gravis
Nov 14, 2023 ·
1m 42s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics...
show more
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal PLOS One on October 10, 2023, titled "Serum metabolomics of treatment response in myasthenia gravis."
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
show less
Read the paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287654
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
